We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Centaur Pharmaceuticals Gets 483 for Hiding, Shredding Documents, Other Quality Lapses
Centaur Pharmaceuticals Gets 483 for Hiding, Shredding Documents, Other Quality Lapses
The FDA slapped Centaur Pharmaceuticals with a 10-observation Form 483 after investigators observed destruction of good manufacturing practice (GMP) documents, among other serious lapses.